Your browser doesn't support javascript.
loading
A Case of Malignant Lymphoma of Lid Margin
Journal of the Korean Ophthalmological Society ; : 2161-2165, 2003.
Artigo em Coreano | WPRIM | ID: wpr-208761
ABSTRACT

PURPOSE:

Masquerade Syndrome that is often misdiagnosed as a conjunctivoblepharitis in the early discovery; It often later becomes identified as Sebaceous gland carcinoma. After carrying out the histopathology of the patient who had been treated at other hospital for six months, we found she had diffuse large B-cell malignant lymphoma.

METHODS:

Before the patient was transferred to our hospital due to no progress of the condition, she had been treated for conjunctivoblepharitis at other hospital for six months. Along the Rt. Upper lid, with expanded capillary vessels, the reddish subcutaneous mass was found, and it took 70% of the whole length of the upper lid. Cilia on mass was all vanished and the right eye had 2 mm of ptosis. The conjunctiva remained the same when we turned the eyelid inside out. There was no tumor connected to orbital floor from the lid. We conducted a histopathology.

RESULTS:

We diagnosed the case as diffuse large B-cell type malignant lymphoma with the results of the histopathology, and the combination chemotherapy remarkably reduced lid mass.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Órbita / Glândulas Sebáceas / Capilares / Linfócitos B / Cílios / Túnica Conjuntiva / Quimioterapia Combinada / Pálpebras / Linfoma Limite: Humanos Idioma: Coreano Revista: Journal of the Korean Ophthalmological Society Ano de publicação: 2003 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Órbita / Glândulas Sebáceas / Capilares / Linfócitos B / Cílios / Túnica Conjuntiva / Quimioterapia Combinada / Pálpebras / Linfoma Limite: Humanos Idioma: Coreano Revista: Journal of the Korean Ophthalmological Society Ano de publicação: 2003 Tipo de documento: Artigo